PRO-DEX, INC. Form PRRN14A: Revised preliminary non-management proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-12-07: Form PRRN14A; Description Revised preliminary non-management proxy statement; Document cg164.htm.
- 2012-11-09: Form PRRN14A; Description PRELIMINARY PROXY STATEMENT; Document aopilp-prrn14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2012-12-07 | PRRN14A | Revised preliminary non-management proxy statement | cg164.htm | |
| 2012-11-09 | PRRN14A | PRELIMINARY PROXY STATEMENT | aopilp-prrn14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |